2.45
-0.15(-5.77%)
Currency In USD
| Previous Close | 2.6 |
| Open | 2.59 |
| Day High | 2.6 |
| Day Low | 2.39 |
| 52-Week High | 2.62 |
| 52-Week Low | 0.4 |
| Volume | 497,699 |
| Average Volume | 389,693 |
| Market Cap | 132.86M |
| PE | -1.22 |
| EPS | -2.01 |
| Moving Average 50 Days | 1.53 |
| Moving Average 200 Days | 1.11 |
| Change | -0.15 |
If you invested $1000 in ALX Oncology Holdings Inc. (ALXO) since IPO date, it would be worth $81.67 as of February 21, 2026 at a share price of $2.45. Whereas If you bought $1000 worth of ALX Oncology Holdings Inc. (ALXO) shares 5 years ago, it would be worth $31.93 as of February 21, 2026 at a share price of $2.45.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
GlobeNewswire Inc.
Feb 19, 2026 1:33 PM GMT
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology”; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ l
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
GlobeNewswire Inc.
Feb 19, 2026 1:30 PM GMT
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ l
ALX Oncology Announces Pricing of Underwritten Offering
GlobeNewswire Inc.
Jan 30, 2026 1:30 PM GMT
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ l